Denikitug is named as a drug or biological intervention in 3 clinical trials in our USA trial register, 2 of which are recruiting. The lead sponsor is Gilead Sciences. Registered phases: Phase 2 and Phase 1. Conditions studied include Advanced Microsatellite Stable Colorectal Cancer; HER2-negative; Gastroesophageal Junction.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07527858 | Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer Advanced Microsatellite Stable Colorectal Cancer |
Phase 2 | Recruiting |
| NCT07546812 | Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas HER2-negative, Gastroesophageal Junction, Esophageal Adenocarcinoma |
Phase 2 | Recruiting |
| NCT05007782 | Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors (ClinicalTrials.gov ↗) Advanced Solid Tumor |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Advanced Microsatellite Stable Colorectal Cancer | 1 |
| HER2-negative | 1 |
| Gastroesophageal Junction | 1 |
| Esophageal Adenocarcinoma | 1 |
| Gastric Adenocarcinoma | 1 |
| Advanced Solid Tumor | 1 |
| Lead sponsor | Trials |
|---|---|
| Gilead Sciences | 3 |
| Register | Denikitug trials |
|---|---|
| Clinical trials in USA | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Denikitug works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Denikitug (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.